mjobserver.com
H.C. Wainwright Analyst Downgrades Shares of Intec Pharma
Senior Healthcare Analyst Raghuram Selvaraju, Ph.D. downgraded their rating on shares of cannabinoid biotechnology innovator Intec Pharma Ltd. (NASDAQ:NTEC) to neutral.